Safety and tolerability of TRAIL receptor agonists in cancer treatment View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2015-05

AUTHORS

Simone Fulda

ABSTRACT

Targeting the death receptor pathway of apoptosis represents a promising approach for the development of novel cancer therapeutics, since death receptors on the cell surface are directly linked to the apoptotic machinery. The tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptor/ligand system is of particular interest among the death receptor superfamily for therapeutic targeting in cancer, since TRAIL has been reported to preferentially induce apoptosis in cancer cells, while sparing non-malignant cells. Evaluation of TRAIL receptor agonists in clinical trials has revealed that they are, in principle, well-tolerated but exert limited efficacy in unselective patient populations. Currently, the challenge resides in the development of rational TRAIL-based combination therapies with potent TRAIL receptor agonists in order to exploit the potential of death receptor targeting for cancer therapy. More... »

PAGES

525-527

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00228-015-1823-1

DOI

http://dx.doi.org/10.1007/s00228-015-1823-1

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1048237537

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/25704217


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Apoptosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Randomized Controlled Trials as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "TNF-Related Apoptosis-Inducing Ligand", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "German Cancer Research Center", 
          "id": "https://www.grid.ac/institutes/grid.7497.d", 
          "name": [
            "Institute for Experimental Cancer Research in Pediatrics, Goethe-University Frankfurt, Komturstr. 3a, 60528, Frankfurt, Germany", 
            "German Cancer Consortium (DKTK), Heidelberg, Germany", 
            "German Cancer Research Center (DKFZ), Heidelberg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fulda", 
        "givenName": "Simone", 
        "id": "sg:person.01331656400.85", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01331656400.85"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1093/annonc/mdt057", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001640266"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1172/jci6926", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009595263"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/0008-5472.can-04-2599", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014250909"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6605507", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018087521", 
          "https://doi.org/10.1038/sj.bjc.6605507"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6605507", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018087521", 
          "https://doi.org/10.1038/sj.bjc.6605507"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2009.25.1991", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019828190"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.cell.2011.02.013", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023540354"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-09-1267", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028547211"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ajh.23822", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029744754"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrd2637", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032375076", 
          "https://doi.org/10.1038/nrd2637"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.cllc.2013.12.005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035059262"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/jto.0b013e31827ce554", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039865173"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cam4.137", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040982858"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6605987", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042600060", 
          "https://doi.org/10.1038/sj.bjc.6605987"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6605987", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042600060", 
          "https://doi.org/10.1038/sj.bjc.6605987"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2011.37.2623", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043016518"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.onc.1209608", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046914764", 
          "https://doi.org/10.1038/sj.onc.1209608"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.onc.1209608", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046914764", 
          "https://doi.org/10.1038/sj.onc.1209608"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2015-05", 
    "datePublishedReg": "2015-05-01", 
    "description": "Targeting the death receptor pathway of apoptosis represents a promising approach for the development of novel cancer therapeutics, since death receptors on the cell surface are directly linked to the apoptotic machinery. The tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptor/ligand system is of particular interest among the death receptor superfamily for therapeutic targeting in cancer, since TRAIL has been reported to preferentially induce apoptosis in cancer cells, while sparing non-malignant cells. Evaluation of TRAIL receptor agonists in clinical trials has revealed that they are, in principle, well-tolerated but exert limited efficacy in unselective patient populations. Currently, the challenge resides in the development of rational TRAIL-based combination therapies with potent TRAIL receptor agonists in order to exploit the potential of death receptor targeting for cancer therapy. ", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00228-015-1823-1", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1054337", 
        "issn": [
          "0031-6970", 
          "1432-1041"
        ], 
        "name": "European Journal of Clinical Pharmacology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "71"
      }
    ], 
    "name": "Safety and tolerability of TRAIL receptor agonists in cancer treatment", 
    "pagination": "525-527", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "e5cc2b039ab6553ad7609012dbce3a7cb47d2153134b5a769016c54115a7de87"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "25704217"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "1256165"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00228-015-1823-1"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1048237537"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00228-015-1823-1", 
      "https://app.dimensions.ai/details/publication/pub.1048237537"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T23:20", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8693_00000491.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007/s00228-015-1823-1"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00228-015-1823-1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00228-015-1823-1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00228-015-1823-1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00228-015-1823-1'


 

This table displays all metadata directly associated to this object as RDF triples.

148 TRIPLES      21 PREDICATES      51 URIs      28 LITERALS      16 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00228-015-1823-1 schema:about N1a11a241ea1e44c69528f0db25d0bbd4
2 N3c8203ff7530430b8a6cd42edc53b23f
3 N59b1a7e8a8da426a9d3b964ff8a80b68
4 N79ba6cd50f844ffdb7fbe20343f012dd
5 N93188447e9ef4683b1ff7bbf1deacf98
6 Nb0fe5a9793314a1582edadb6d342147f
7 Nb1d448bce38e40c6b646a4fa42b98691
8 anzsrc-for:11
9 anzsrc-for:1112
10 schema:author Ncd5fd19e8d034a10864c86112b4d25f8
11 schema:citation sg:pub.10.1038/nrd2637
12 sg:pub.10.1038/sj.bjc.6605507
13 sg:pub.10.1038/sj.bjc.6605987
14 sg:pub.10.1038/sj.onc.1209608
15 https://doi.org/10.1002/ajh.23822
16 https://doi.org/10.1002/cam4.137
17 https://doi.org/10.1016/j.cell.2011.02.013
18 https://doi.org/10.1016/j.cllc.2013.12.005
19 https://doi.org/10.1093/annonc/mdt057
20 https://doi.org/10.1097/jto.0b013e31827ce554
21 https://doi.org/10.1158/0008-5472.can-04-2599
22 https://doi.org/10.1158/1078-0432.ccr-09-1267
23 https://doi.org/10.1172/jci6926
24 https://doi.org/10.1200/jco.2009.25.1991
25 https://doi.org/10.1200/jco.2011.37.2623
26 schema:datePublished 2015-05
27 schema:datePublishedReg 2015-05-01
28 schema:description Targeting the death receptor pathway of apoptosis represents a promising approach for the development of novel cancer therapeutics, since death receptors on the cell surface are directly linked to the apoptotic machinery. The tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptor/ligand system is of particular interest among the death receptor superfamily for therapeutic targeting in cancer, since TRAIL has been reported to preferentially induce apoptosis in cancer cells, while sparing non-malignant cells. Evaluation of TRAIL receptor agonists in clinical trials has revealed that they are, in principle, well-tolerated but exert limited efficacy in unselective patient populations. Currently, the challenge resides in the development of rational TRAIL-based combination therapies with potent TRAIL receptor agonists in order to exploit the potential of death receptor targeting for cancer therapy.
29 schema:genre research_article
30 schema:inLanguage en
31 schema:isAccessibleForFree false
32 schema:isPartOf Na2cbc4ccd1b64cf9a618ec51f1d6adfa
33 Na7127fa5d7c94e1b9b4af18fb2b73983
34 sg:journal.1054337
35 schema:name Safety and tolerability of TRAIL receptor agonists in cancer treatment
36 schema:pagination 525-527
37 schema:productId N1ba0c5c39854450183e3267ba44a5e0c
38 N6f8eb82eaeb64d44a066ec9d089e6f5e
39 Naf648b365fea486bb12d4ef28266c6d0
40 Ne27a42a70a3846f4b11957daba607589
41 Nef55b61d5eba42e0a6505494fe43bfaa
42 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048237537
43 https://doi.org/10.1007/s00228-015-1823-1
44 schema:sdDatePublished 2019-04-10T23:20
45 schema:sdLicense https://scigraph.springernature.com/explorer/license/
46 schema:sdPublisher Ne6b322c299f84550b4691c28726e8c44
47 schema:url http://link.springer.com/10.1007/s00228-015-1823-1
48 sgo:license sg:explorer/license/
49 sgo:sdDataset articles
50 rdf:type schema:ScholarlyArticle
51 N1a11a241ea1e44c69528f0db25d0bbd4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
52 schema:name Antineoplastic Agents
53 rdf:type schema:DefinedTerm
54 N1ba0c5c39854450183e3267ba44a5e0c schema:name dimensions_id
55 schema:value pub.1048237537
56 rdf:type schema:PropertyValue
57 N3c8203ff7530430b8a6cd42edc53b23f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
58 schema:name TNF-Related Apoptosis-Inducing Ligand
59 rdf:type schema:DefinedTerm
60 N59b1a7e8a8da426a9d3b964ff8a80b68 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
61 schema:name Humans
62 rdf:type schema:DefinedTerm
63 N6f8eb82eaeb64d44a066ec9d089e6f5e schema:name nlm_unique_id
64 schema:value 1256165
65 rdf:type schema:PropertyValue
66 N79ba6cd50f844ffdb7fbe20343f012dd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
67 schema:name Randomized Controlled Trials as Topic
68 rdf:type schema:DefinedTerm
69 N93188447e9ef4683b1ff7bbf1deacf98 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
70 schema:name Apoptosis
71 rdf:type schema:DefinedTerm
72 Na2cbc4ccd1b64cf9a618ec51f1d6adfa schema:volumeNumber 71
73 rdf:type schema:PublicationVolume
74 Na7127fa5d7c94e1b9b4af18fb2b73983 schema:issueNumber 5
75 rdf:type schema:PublicationIssue
76 Naf648b365fea486bb12d4ef28266c6d0 schema:name doi
77 schema:value 10.1007/s00228-015-1823-1
78 rdf:type schema:PropertyValue
79 Nb0fe5a9793314a1582edadb6d342147f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
80 schema:name Neoplasms
81 rdf:type schema:DefinedTerm
82 Nb1d448bce38e40c6b646a4fa42b98691 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
83 schema:name Treatment Outcome
84 rdf:type schema:DefinedTerm
85 Ncd5fd19e8d034a10864c86112b4d25f8 rdf:first sg:person.01331656400.85
86 rdf:rest rdf:nil
87 Ne27a42a70a3846f4b11957daba607589 schema:name readcube_id
88 schema:value e5cc2b039ab6553ad7609012dbce3a7cb47d2153134b5a769016c54115a7de87
89 rdf:type schema:PropertyValue
90 Ne6b322c299f84550b4691c28726e8c44 schema:name Springer Nature - SN SciGraph project
91 rdf:type schema:Organization
92 Nef55b61d5eba42e0a6505494fe43bfaa schema:name pubmed_id
93 schema:value 25704217
94 rdf:type schema:PropertyValue
95 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
96 schema:name Medical and Health Sciences
97 rdf:type schema:DefinedTerm
98 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
99 schema:name Oncology and Carcinogenesis
100 rdf:type schema:DefinedTerm
101 sg:journal.1054337 schema:issn 0031-6970
102 1432-1041
103 schema:name European Journal of Clinical Pharmacology
104 rdf:type schema:Periodical
105 sg:person.01331656400.85 schema:affiliation https://www.grid.ac/institutes/grid.7497.d
106 schema:familyName Fulda
107 schema:givenName Simone
108 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01331656400.85
109 rdf:type schema:Person
110 sg:pub.10.1038/nrd2637 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032375076
111 https://doi.org/10.1038/nrd2637
112 rdf:type schema:CreativeWork
113 sg:pub.10.1038/sj.bjc.6605507 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018087521
114 https://doi.org/10.1038/sj.bjc.6605507
115 rdf:type schema:CreativeWork
116 sg:pub.10.1038/sj.bjc.6605987 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042600060
117 https://doi.org/10.1038/sj.bjc.6605987
118 rdf:type schema:CreativeWork
119 sg:pub.10.1038/sj.onc.1209608 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046914764
120 https://doi.org/10.1038/sj.onc.1209608
121 rdf:type schema:CreativeWork
122 https://doi.org/10.1002/ajh.23822 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029744754
123 rdf:type schema:CreativeWork
124 https://doi.org/10.1002/cam4.137 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040982858
125 rdf:type schema:CreativeWork
126 https://doi.org/10.1016/j.cell.2011.02.013 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023540354
127 rdf:type schema:CreativeWork
128 https://doi.org/10.1016/j.cllc.2013.12.005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035059262
129 rdf:type schema:CreativeWork
130 https://doi.org/10.1093/annonc/mdt057 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001640266
131 rdf:type schema:CreativeWork
132 https://doi.org/10.1097/jto.0b013e31827ce554 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039865173
133 rdf:type schema:CreativeWork
134 https://doi.org/10.1158/0008-5472.can-04-2599 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014250909
135 rdf:type schema:CreativeWork
136 https://doi.org/10.1158/1078-0432.ccr-09-1267 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028547211
137 rdf:type schema:CreativeWork
138 https://doi.org/10.1172/jci6926 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009595263
139 rdf:type schema:CreativeWork
140 https://doi.org/10.1200/jco.2009.25.1991 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019828190
141 rdf:type schema:CreativeWork
142 https://doi.org/10.1200/jco.2011.37.2623 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043016518
143 rdf:type schema:CreativeWork
144 https://www.grid.ac/institutes/grid.7497.d schema:alternateName German Cancer Research Center
145 schema:name German Cancer Consortium (DKTK), Heidelberg, Germany
146 German Cancer Research Center (DKFZ), Heidelberg, Germany
147 Institute for Experimental Cancer Research in Pediatrics, Goethe-University Frankfurt, Komturstr. 3a, 60528, Frankfurt, Germany
148 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...